share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144：擬議出售證券
美股sec公告 ·  03/22 04:42
牛牛AI助理已提取核心訊息
Recursion Pharmaceuticals, Inc. officer, Marriott Tina, is set to sell 8,000 Class A shares on 03/21/2024, as per the latest filing. The shares, valued at approximately $85,980.09, were originally acquired on the same date through options granted on 07/23/2018. The transaction is part of a pre-planned trading arrangement established on 03/01/2023. Over the past three months, Tina has sold a total of 24,000 shares, generating gross proceeds of $286,576.3.
Recursion Pharmaceuticals, Inc. officer, Marriott Tina, is set to sell 8,000 Class A shares on 03/21/2024, as per the latest filing. The shares, valued at approximately $85,980.09, were originally acquired on the same date through options granted on 07/23/2018. The transaction is part of a pre-planned trading arrangement established on 03/01/2023. Over the past three months, Tina has sold a total of 24,000 shares, generating gross proceeds of $286,576.3.
最新文件顯示，Recursion Pharmicals, Inc.高管萬豪蒂娜定於2024年3月21日出售8,000股A類股票。這些股票價值約85,980.09美元，最初是通過2018年7月23日授予的期權於同日收購的。該交易是2023年1月3日訂立的預先計劃的交易安排的一部分。在過去的三個月中，蒂娜共出售了24,000股股票，總收益爲286,576.3美元。
最新文件顯示，Recursion Pharmicals, Inc.高管萬豪蒂娜定於2024年3月21日出售8,000股A類股票。這些股票價值約85,980.09美元，最初是通過2018年7月23日授予的期權於同日收購的。該交易是2023年1月3日訂立的預先計劃的交易安排的一部分。在過去的三個月中，蒂娜共出售了24,000股股票，總收益爲286,576.3美元。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。